Stockreport

Dianthus Therapeutics' (DNTH) CFO Sold 8,224 Shares for $739,000 [Globe and Mail, The (Toronto, Canada)]

Dianthus Therapeutics, Inc.  (DNTH) 
PDF This transaction represented 100.00% of Mr. Savitz's direct common stock holdings, reducing his direct and indirect ownership in this class to zero shares. The transa [Read more]